Jun 4, 2026 08:00AM
May 29, 2026 04:01PM
May 12, 2026 07:05AM
May 12, 2026 07:01AM
May 12, 2026 07:00AM
May 12, 2026 07:00AM
May 5, 2026 07:00AM Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026
May 1, 2026 03:39PM
May 1, 2026 01:12PM
May 1, 2026 12:43PM
May 1, 2026 12:43PM
Feb 24, 2026 07:00AM
Dec 21, 2025 04:00AM
Nov 24, 2025 07:02AM Arvinas to present vepdegestrant data at breast cancer symposium
Nov 24, 2025 07:00AM
Nov 5, 2025 07:00AM
Oct 20, 2025 04:15AM
Oct 13, 2025 07:00AM
Sep 24, 2025 02:35AM
Sep 19, 2025 04:47AM
Sep 17, 2025 04:31PM Arvinas and Pfizer to out-license vepdegestrant commercialization rights
Sep 17, 2025 04:30PM
Aug 8, 2025 04:05PM
Aug 8, 2025 04:05PM
Aug 6, 2025 07:00AM
Jun 11, 2025 08:30AM
Jun 6, 2025 08:38AM
Jun 6, 2025 07:01AM Arvinas Inc. (ARVN) Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
Jun 6, 2025 07:00AM
May 31, 2025 08:00AM
May 31, 2025 08:00AM
May 1, 2025 07:00AM
Apr 23, 2025 10:45AM
Apr 23, 2025 10:44AM
Apr 9, 2025 09:34AM Arvinas Inc. (ARVN) PT Lowered to $21 at Truist Securities
Mar 11, 2025 06:46AM
Mar 11, 2025 06:45AM
Feb 11, 2025 07:00AM
Jan 10, 2025 07:08AM
Jan 10, 2025 07:00AM
Dec 22, 2024 04:00AM
Dec 10, 2024 09:09AM Arvinas (ARVN) and Pfizer (PFE) Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium
Dec 10, 2024 09:05AM
Nov 25, 2024 05:35PM
Oct 30, 2024 07:00AM
Jul 30, 2024 07:00AM
Jul 22, 2024 08:31AM
Jul 22, 2024 08:30AM
Jul 15, 2024 08:00AM Milestone Pharmaceuticals Refreshes Board of Directors
May 23, 2024 05:00PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All